# US 2008/0306266 A1 · Process for Preparing 2-Methyl-1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306266 A1
- Document ID: US20080306266A1
- Status: Published application
- Kind: A1
- Application number: 11/794,584
- Filed: 2005-12-18
- Published: 2008-12-11
- Earliest claimed: 2004-12-30
- Assignees: 3M Innovative Properties Company
- Inventors: Hugues Martin; David Ach; Clement Toussaint; Fabrice Dubois
- Web page: https://patentgrep.com/patent/US20080306266A1

## CPC

- C07D 471/14: Ortho-condensed systems
- A61P 31/12: Antivirals
- A61P 35/00: Antineoplastic agents
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides various processes for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

## Claims

### Claim 1

A method for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine, the method comprising:
providing 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine in a carrier comprising a lower alcohol;
combining the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine in the carrier with an ammonia- or ammonium-containing reagent and an arylsulfonyl halide to form a mixture; and
allowing the components of the mixture to react for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

### Claim 2 (depends on 1)

The method of claim 1 further comprising combining the mixture with an aqueous base.

### Claim 3 (depends on 2)

The method of claim 2 wherein sufficient aqueous base is added to adjust the mixture to a pH of greater than 8.

### Claim 4 (depends on 3)

The method of claim 3 wherein the aqueous base comprises aqueous sodium hydroxide.

### Claim 5 (depends on 1)

The method of claim 1 wherein the ammonia- or ammonium-containing reagent comprises ammonium hydroxide in water.

### Claim 6 (depends on 5)

The method of claim 5 wherein the ammonia- or ammonium-containing reagent comprises less than ten equivalents of ammonium hydroxide.

### Claim 7 (depends on 1)

The method of claim 1 wherein the arylsulfonyl halide is benzenesulfonyl chloride or p-toluenesulfonyl chloride.

### Claim 8 (depends on 1)

The method of claim 1 wherein the period of time sufficient to form 2-methyl-1-(2-methylpropyl)-1H imidazo[4,5-c][1,5]naphthyridin-4-amine is 45 minutes to 75 minutes.

### Claim 9 (depends on 1)

The method of claim 1 wherein providing 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine in a carrier comprising a lower alcohol; combining the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine in the carrier with an ammonia- or ammonium-containing reagent and an arylsulfonyl halide to form a mixture; and allowing the components of the mixture to react for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine are carried out at a temperature of 20° C. to 30° C.

### Claim 10 (depends on 1)

The method of claim 1 wherein the ammonia- or ammonium-containing reagent is added prior to the arylsulfonyl halide.

### Claim 11 (depends on 1)

The method of claim 1 further comprising cooling the mixture to a temperature of 5° C. to 15° C.

### Claim 12 (depends on 1)

The method of claim 1 further comprising separating at least a portion of the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine from at least a portion of the mixture.

### Claim 13 (depends on 12)

The method of claim 12 further comprising washing and at least partially drying the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

### Claim 14 (depends on 1)

The method of claim 1 wherein providing 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine comprises:
providing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine in a carrier comprising a non-chlorinated solvent at a temperature of 25° C. to 70° C.;
combining the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine in the carrier with an oxidizing agent to form a mixture and maintaining the mixture at a temperature of 25° C. to 70° C. for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine; and
isolating at least a portion of the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 15 (depends on 14)

The method of claim 14 wherein the non-chlorinated solvent is selected from the group consisting of toluene, butyl acetate, ethyl acetate, and combinations thereof.

### Claim 16 (depends on 15)

The method of claim 15 wherein the non-chlorinated solvent is toluene.

### Claim 17 (depends on 14)

The method of claim 14 wherein the oxidizing agent comprises peracetic acid.

### Claim 18 (depends on 14)

The method of claim 14 wherein the period of time sufficient to form 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine comprises a period of time sufficient to react at least 80% of the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 19 (depends on 18)

The method of claim 18 wherein the period of time sufficient to react at least 80% of the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine is 5 hours to 7 hours.

### Claim 20 (depends on 14)

The method of claim 14 wherein isolating the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine comprises:
combining the mixture comprising the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine with an aqueous solution of a reducing agent followed by an aqueous base;
cooling the mixture to form solid 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine; and
separating at least a portion of the solid 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine from at least a portion of the mixture.

### Claim 21 (depends on 20)

The method of claim 20 wherein the reducing agent is selected from the group consisting of sodium metabisulfite, sodium sulfite, ferrous sulfate, and combinations thereof.

### Claim 22 (depends on 21)

The method of claim 21 wherein the reducing agent is sodium metabisulfite.

### Claim 23 (depends on 22)

The method of claim 22 wherein combining the mixture comprising the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine with an aqueous solution of sodium metabisulfite followed by an aqueous base comprises combining the mixture with an aqueous solution of 0.1 equivalent to 0.3 equivalent of sodium metabisulfite followed by a sufficient amount of aqueous base to adjust the mixture to a pH of greater than 10.

### Claim 24 (depends on 22, 23)

The method of claim 22 or claim 23 wherein combining the mixture comprising the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine with an aqueous solution of sodium metabisulfite followed by an aqueous base comprises combining six to ten milliliters of water per gram of 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine with a mixture comprising eight to twelve milliliters of toluene per gram of 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 25 (depends on 24)

The method of claim 24 wherein the volume ratio of water to toluene is 0.8:1.

### Claim 26 (depends on 20)

The method of claim 20 wherein cooling the mixture comprises cooling the mixture to a temperature of 0° C. to 20° C.

### Claim 27 (depends on 14)

The method of claim 14 wherein combining the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine with an oxidizing agent comprises combining the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine with at least one equivalent of peracetic acid.

### Claim 28 (depends on 14)

The method of claim 14 wherein providing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine comprises:
providing N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in a carrier comprising a non-chlorinated solvent at a temperature of 18° C. to 30° C.;
combining the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in the carrier with an organic acid to form a mixture;
combining the mixture comprising the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine and organic acid with a trialkyl orthoacetate at a temperature of 70° C. to 100° C.; and
maintaining the temperature at 70° C. to 100° C. for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 29 (depends on 28)

The method of claim 28 wherein the organic acid is selected from the group consisting of p-toluenesulfonic acid, trifluoroacetic acid, ethanesulfonic acid, and mixtures thereof.

### Claim 30 (depends on 29)

The method of claim 29 wherein the organic acid is p-toluenesulfonic acid.

### Claim 31 (depends on 28)

The method of claim 28 wherein the trialkyl orthoacetate is triethyl orthoacetate.

### Claim 32 (depends on 28)

The method of claim 28 wherein the non-chlorinated solvent is selected from the group consisting of toluene, butyl acetate, ethyl acetate, and combinations thereof.

### Claim 33 (depends on 32)

The method of claim 32 wherein the non-chlorinated solvent is toluene.

### Claim 34 (depends on 28)

The method of claim 28 further comprising cooling the mixture comprising 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine to a temperature of 25° C. to 70° C.

### Claim 35 (depends on 28)

The method of claim 28 wherein the 2-methyl-1-(2-methylpropyl)-1H imidazo[4,5-c][1,5]naphthyridine is not isolated prior to combining it with the oxidizing agent.

### Claim 36 (depends on 28)

The method of claim 28 wherein combining the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine with an organic acid comprises combining the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine with 0.02 equivalent to 0.08 equivalent of the organic acid.

### Claim 37 (depends on 28)

The method of claim 28 wherein combining the mixture comprising the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine and organic acid with a trialkyl orthoacetate comprises combining the mixture comprising the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine and organic acid with at least one equivalent of the trialkyl orthoacetate.

### Claim 38 (depends on 28)

The method of claim 28 wherein maintaining the temperature at 70° C. to 100° C. for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine comprises maintaining the temperature at 70° C. to 100° C. for at least 30 minutes.

### Claim 39 (depends on 28)

The method of claim 28 wherein providing N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine comprises:
providing N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in a carrier comprising a non-chlorinated solvent;
combining the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in the carrier with a hydrogenation catalyst to form a mixture;
subjecting the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine and the hydrogenation catalyst to a hydrogen atmosphere under conditions effective to form N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine; and
removing at least a portion of the hydrogenation catalyst from the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine.

### Claim 40 (depends on 39)

The method of claim 39 wherein the non-chlorinated solvent is selected from the group consisting of toluene, butyl acetate, ethyl acetate, and combinations thereof.

### Claim 41 (depends on 40)

The method of claim 40 wherein the non-chlorinated solvent is toluene.

### Claim 42 (depends on 39)

The method of claim 39 wherein combining the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in the carrier with a hydrogenation catalyst comprises combining the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in the carrier with a hydrogenation catalyst and isopropanol to form a mixture.

### Claim 43 (depends on 42)

The method of claim 42 further comprising removing at least a portion of the isopropanol from the mixture of N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in a carrier comprising toluene and isopropanol.

### Claim 44 (depends on 39)

The method of claim 39 wherein the hydrogenation catalyst comprises platinum on carbon.

### Claim 45 (depends on 39)

The method of claim 39 wherein the conditions effective to form N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine comprise a temperature of 15° C. to 30° C.

### Claim 46 (depends on 39)

The method of claim 39 wherein the conditions effective to form N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine comprise a hydrogen pressure of 1×105 Pa to 3×105 Pa.

### Claim 47 (depends on 39)

The method of claim 39 wherein the conditions effective to form N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine comprise a time period of at least 3 hours.

### Claim 48 (depends on 39)

The method of claim 39 wherein the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine is not isolated prior to combining it with the organic acid.

### Claim 49 (depends on 39)

The method of claim 39 wherein providing N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine comprises:
providing 4-chloro-3-nitro[1,5]naphthyridine in a carrier comprising a water-miscible organic liquid;
combining the 4-chloro-3-nitro[1,5]naphthyridine in the carrier with isobutylamine under conditions effective to form a mixture comprising N4-(2-methylpropyl)-3-nitro[1,5]naphthyridine-4-amine;
combining the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine with water to form solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine; and
separating at least a portion of solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine from at least a portion of the mixture comprising the water.

### Claim 50 (depends on 49)

The method of claim 49 wherein the water-miscible organic liquid is selected from the group consisting of tetrahydrofuran, dichloromethane, acetonitrile, and mixtures thereof.

### Claim 51 (depends on 50)

The method of claim 50 wherein the water-miscible organic liquid is tetrahydrofuran.

### Claim 52 (depends on 49)

The method of claim 49 wherein the conditions effective to form a mixture comprising N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine comprise a temperature of 15° C. to 30° C.

### Claim 53 (depends on 49)

The method of claim 49 wherein combining the 4-chloro-3-nitro[1,5]naphthyridine with isobutylamine comprises combining the 4-chloro-3-nitro[1,5]naphthyridine with at least two equivalents of isobutylamine.

### Claim 54 (depends on 49)

The method of claim 49 wherein separating at least a portion of the solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine comprises filtering the solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine.

### Claim 55 (depends on 54)

The method of claim 54 further comprising washing and drying the solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine.

### Claim 56 (depends on 49)

The method of claim 49 wherein providing 4-chloro-3-nitro[1,5]naphthyridine comprises:
providing 3-nitro[1,5]naphthyridin-4-ol in a carrier comprising N,N-dimethylformamide;
combining the 3-nitro[1,5]naphthyridin-4-ol in the carrier with phosphorous oxychloride under conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine;
combining the mixture comprising the 4-chloro-3-nitro[1,5]naphthyridine with water under conditions effective to form solid 4-chloro-3-nitro[1,5]naphthyridine; and
separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine from at least a portion of the mixture comprising the water.

### Claim 57 (depends on 56)

The method of claim 56 wherein the conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine comprise a temperature of 15° C. to 35° C.

### Claim 58 (depends on 56)

The method of claim 56 wherein the conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine comprise a time period of at least one hour.

### Claim 59 (depends on 56)

The method of claim 56 wherein the conditions effective to form solid 4-chloro-3-nitro[1,5]naphthyridine comprise cooling the mixture comprising the water to a temperature of less than 20° C.

### Claim 60 (depends on 56)

The method of claim 56 wherein combining the 3-nitro[1,5]naphthyridin-4-ol with phosphorous oxychloride comprises combining the 3-nitro[1,5]naphthyridin-4-ol with at least one equivalent of phosphorous oxychloride.

### Claim 61 (depends on 56)

The method of claim 56 wherein separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine comprises filtering the solid 4-chloro-3-nitro[1,5]naphthyridine from the mixture comprising the water.

### Claim 62 (depends on 56)

The method of claim 56 wherein separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine occurs less than 30 minutes after combining the mixture comprising the 4-chloro-3-nitro[1,5]naphthyridine with water.

### Claim 63 (depends on 56)

The method of claim 56 wherein the solid 4-chloro-3-nitro[1,5]naphthyridine is combined with isobutylamine within less than 4 hours of its preparation.

### Claim 64 (depends on 1)

The method of claim 1 wherein providing 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine comprises:
providing 3-nitro-1,5-naphthyridin-4-ol in a carrier comprising N,N-dimethylformamide;
combining the 3-nitro[1,5]naphthyridin-4-ol in the carrier with phosphorous oxychloride under conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine;
combining the mixture comprising the 4-chloro-3-nitro[1,5]naphthyridine with water under conditions effective to form solid 4-chloro-3-nitro[1,5]naphthyridine;
separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine from at least a portion of the mixture comprising the water;
combining the separated solid 4-chloro-3-nitro[1,5]naphthyridine with a carrier comprising a water-miscible organic liquid;
combining the 4-chloro-3-nitro[1,5]naphthyridine in the carrier with isobutylamine under conditions effective to form a mixture comprising N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine;
combining the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine with water to form solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine;
separating at least a portion of solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine from at least a portion of the mixture comprising the water; and
converting the solid .N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine to 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 65

A method of making N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine, the method comprises:
providing 3-nitro[1,5]naphthyridin-4-ol in a carrier comprising N,N-dimethylformamide;
combining the 3-nitro[1,5]naphthyridin-4-ol in the carrier with phosphorous oxychloride under conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine;
combining the mixture comprising the 4-chloro-3-nitro[1,5]naphthyridine with water under conditions effective to form solid 4-chloro-3-nitro[1,5]naphthyridine;
separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine from at least a portion of the mixture comprising the water;
combining the separated solid 4-chloro-3-nitro[1,5]naphthyridine with a carrier comprising tetrahydrofuran;
combining the 4-chloro-3-nitro[1,5]naphthyridine in the carrier with isobutylamine under conditions effective to form a mixture comprising N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine;
combining the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine with water to form solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine; and
separating at least a portion of solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine from at least a portion of the mixture comprising the water.

### Claim 66

A method of making 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine, the method comprising:
providing N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in a carrier comprising toluene;
combining the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine in the carrier with a hydrogenation catalyst and isopropanol to form a mixture;
subjecting the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridine-4-amine and the hydrogenation catalyst to a hydrogen atmosphere under conditions effective to form N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine;
removing at least a portion of the hydrogenation catalyst from the N4-(2-methylpropyl) [1,5]naphthyridine-3,4-diamine;
removing at least a portion of the isopropanol from the mixture of N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in a carrier comprising toluene and isopropanol;
heating the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in the carrier to a temperature of 20° C. to 55° C.;
combining the N4-(2-methylpropyl)[1,5]naphthyridine-3,4-diamine in the carrier with p-toluenesulfonic acid to form a mixture;
combining the mixture comprising the N4-(2-methylpropyl) [1,5]naphthyridine-3,4-diamine and p-toluenesulfonic acid with a trialkyl orthoacetate at a temperature of 70° C. to 100° C.;
maintaining the temperature at 70° C. to 100° C. for a period time sufficient to form 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine;
cooling the mixture comprising 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine to a temperature of 45° C. to 55° C.;
combining the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine in the carrier with an oxidizing agent comprising peracetic acid to form a mixture;
maintaining the mixture comprising the 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridine and peracetic acid at a temperature of 45° C. to 55° C. for a period of time sufficient to form 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine; and
isolating at least a portion of the 2-methyl-1-(2-methylpropyl)-5-oxido-1H-imidazo[4,5-c][1,5]naphthyridine.

### Claim 67 (depends on 66)

The method of claim 66 wherein providing N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine comprises:
providing 3-nitro[1,5]naphthyridin-4-ol in a carrier comprising N,N-dimethylformamide;
combining the 3-nitro[1,5]naphthyridin-4-ol in the carrier with phosphorous oxychloride under conditions effective to form 4-chloro-3-nitro[1,5]naphthyridine;
combining the mixture comprising the 4-chloro-3-nitro[1,5]naphthyridine with water under conditions effective to form solid 4-chloro-3-nitro[1,5]naphthyridine;
separating at least a portion of the solid 4-chloro-3-nitro[1,5]naphthyridine from at least a portion of the mixture comprising the water;
combining the separated solid 4-chloro-3-nitro[1,5]naphthyridine with a carrier comprising tetrahydrofuran;
combining the 4-chloro-3-nitro[1,5]naphthyridine in the carrier with isobutylamine under conditions effective to form a mixture comprising N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine;
combining the mixture comprising the N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine with water to form solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine; and
separating at least a portion of solid N4-(2-methylpropyl)-3-nitro[1,5]naphthyridin-4-amine from at least a portion of the mixture comprising the water.
